Bivalency of natalizumab promotes inhibition of dynamic VLA-4 adhesion beyond affinity gain
Valignat, M.-P.; Biarnes, M.; Touchard, D.; Ricco, A.; Chames, P.; Theodoly, O.; Robert, P.
Show abstract
Natalizumab, a monoclonal IgG4 antibody used in the treatment of multiple sclerosis (MS), inhibits VLA-4 binding to VCAM-1, thereby reducing leukocyte recruitment to inflamed tissues. The intricate mechanisms underlying these effects remain unclear, particularly concerning the heavy-chain shuffling of IgG4. We conducted an in vitro study to quantify the impact of bivalent IgG and monovalent Fab forms of natalizumab on the capture and migration of human primary memory T lymphocytes under shear stress, using VCAM-1 and SDF-1-coated surfaces. IgG natalizumab at concentrations near its cell surface EC50 showed significant of capture and resistance of adherent cells to shear stress, whereas significantly higher doses of Fab natalizumab, up to 100-fold greater than its cell surface EC50, were needed to achieve similar effects. These findings highlight that receptor occupancy alone may not adequately predict the functional outcomes of inhibitor antibodies. For optimal therapeutic effect, inhibition of cell-surface adhesion may require specific kinetic and geometric binding properties of antibodies.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Human Fcγ-receptors selectively respond to C-reactive protein (CRP) isoforms 94%
- Opsonization by non-neutralizing antibodies can confer protection to SARS-CoV-2 despite Spike-dependent modulation of phagocytosis 93%
- Live-cell microscopy reveals that human T cells primarily respond chemokinetically within a CCL19 gradient that induces chemotaxis in dendritic cells 93%
Similar papers in this journal
Similar papers in this journal
- Monoclonal Antibodies Capable of Binding SARS-CoV-2 Spike Protein Receptor Binding Motif Specifically Prevent GM-CSF Induction. 93%
- Differential glycosylation of alpha-1-acid glycoprotein (AGP-1) contributes to its functional diversity. 93%
- Functional selective FPR1 signaling in favor of an activation of the neutrophil superoxide generating NOX2-complex 92%
Similar papers in this journal
- A mechanistically novel peptide agonist of the IL-7 receptor that addresses limitations of IL-7 cytokine therapy 93%
- Targeting prostate cancer by new bispecific monocyte engager directed to prostate-specific membrane antigen 92%
- Platelet, erythrocyte, endothelial, and monocyte microparticles in coagulation activation and propagation 91%
Similar papers in this journal
- Relieving platelet inhibition using a novel bi-specific antibody:A novel approach for circumventing the platelet storage lesion 92%
- Alpha-hemolysin of Staphylococcus aureus impairs thrombus formation 92%
- Quantitative super-resolution imaging of platelet degranulation reveals differential release of VWF and VWF propeptide from alpha-granules 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.